Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: Bioavailability Study of Clonazepam ODT Under Fasting Conditions [Phase 1]
This document notes the completion of a Phase 1 bioavailability study of clonazepam orally disintegrating tablets under fasting conditions t…
-
FDA approval · 2008-03-21FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2008-03-13FDA Approved: PAROXETINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic paroxetine product (paroxetine hydrochloride hemihydrate) from Mylan Pharmaceuticals Inc. under an original ANDA.
-
FDA approval · 2008-03-09FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2008-03-06FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Mylan Pharmaceuticals Inc., indicating approval of a supplemen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression [Phase 4]
Phase 4 clinical trial update reporting completion of a study evaluating clonazepam and paroxetine for panic disorder with depression.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Ventilatory Physiology in Children at Risk for Anxiety
This update reports a completed clinical trial studying ventilatory physiology in children at risk for anxiety and panic disorder.
-
FDA approval · 2008-02-28FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for alprazolam from Sandoz Inc, updating the regulatory status of the product.
-
FDA approval · 2008-02-14FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine from Chartwell Governmental & Specialty RX, LLC.
-
FDA label_change · 2008-02-07FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic paroxetine hydrochloride product (PAROXETINE HYDROCHLORIDE).
-
FDA approval · 2008-01-31FDA Approved: FLUOXETINE — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved the original application for a generic fluoxetine hydrochloride product from Quallent Pharmaceuticals Health LLC.
-
FDA label_change · 2008-01-30FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC, updating the product labe…
-
FDA approval · 2008-01-11FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a sertraline generic product from Heritage Pharmaceuticals (Avet), authorizing changes to the ap…
-
FDA approval · 2008-01-08FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s sertraline hydrochloride generic under an Original Application. The approval provides a generic…
-
FDA approval · 2007-12-26FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for SERTRALINE HYDROCHLORIDE (generic) from Aurobindo Pharma Limited, updating the regulatory status…
-
FDA approval · 2007-12-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-11-28FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc. under ANDA074312, granting regulatory clearan…
-
FDA approval · 2007-10-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, a generic sertraline product, under the ANDA.
-
CLINICAL_TRIALS trial_result · 2007-10-22Clinical Trial Update: A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients [Phase 4]
A Phase 4 trial comparing sertraline alone to sertraline with early alprazolam XR in panic disorder has completed.
-
FDA approval · 2007-10-10FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved Lannett Company's supplemental application for fluoxetine hydrochloride, a generic version of fluoxetine.
-
CLINICAL_TRIALS trial_result · 2007-10-05Clinical Trial Update: Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder [Phase 4]
Phase 4 trial evaluating paroxetine versus placebo, each with either aerobic exercise or relaxation, for panic disorder has completed.
-
FDA approval · 2007-09-20FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS research · 2007-08-14Clinical Trial Update: Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy
This update discusses genetic abnormalities and biological changes in panic disorder patients after pharmacotherapy. The current status of t…
-
CLINICAL_TRIALS trial_result · 2007-08-08Clinical Trial Update: Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release [Phase 4]
Phase 4 clinical trial exploring the costs of lost productive time among Korean workers with panic disorder and the impact of treatment with…